ADAG
Adagene Inc. American Depositary Shares
$1.950+-0.000 (-0.000%)
Prix en Temps Réel
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$1.950
Haut
$1.950
Bas
$1.950
Volume
0.00M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
GlobeNewswire
Adagene to Present at Jefferies Global Healthcare Conference 2025
SAN DIEGO and SUZHOU, China, May 27, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that
Voir plus
GlobeNewswire
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events In combination with pembrolizumab, ADG126 showed a 29% confirmed overall response rate (ORR)
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.